Report date: 2026-11-16
Analysis focus
Provide a balanced, comprehensive analysis: fundamentals and valuation, the Wall Street view, technical posture, and the key forward risks and catalysts.
Summary
Findings (23)
ASML reported Q3 2026 total net sales of €11,662 million, up from €9,326 million in Q2 2026, with a gross margin of 57.5%, net income of €4,960 million and basic EPS of €12.95 (diluted €12.93); Installed Base Management sales were €3,289 million and the company sold 113 new and 8 used lithography systems.
High confidenceASML's 6-K earnings release filed with the SEC (primary source) lists these exact Q3 2026 figures, and the company press release republished on Seeking Alpha matches them.
ASML guided Q4 2026 net sales to €14.2–15.2 billion at a gross margin of about 57%, and full-year 2026 net sales to €44–45 billion at a gross margin of about 56%; the CEO said planned 2027–2028 supply 'will not fully meet the demand of our customers', and the company plans a 30% increase in low-NA EUV and DUV immersion capacity in 2027.
High confidenceThe guidance and CEO Christophe Fouquet's capacity comments appear in the primary 6-K release. The release does not disclose a quarterly net bookings figure, so customer interest in 2029–2030 orders should not be read as firm backlog.
MarketBeat lists ASML's ADR (NASDAQ: ASML) consensus as "Moderate Buy" across 24 ratings (2 Strong Buy, 17 Buy, 2 Hold, 3 Sell), with an average 12-month price target of $2,204.71.
High confidenceMarketBeat's November 9 and November 11, 2026 alerts give the same rating breakdown and the same $2,204.71 average target. Other aggregators differ: Investing.com shows an average of about $2,137 from 40 Buy, 3 Hold and 1 Sell over the last three months, and AlphaSpread shows €2,127.38 from 39 analysts for the Euro listing. The differences come from the share class, the set of analysts counted, and the snapshot date. No median target was found in the sources reviewed.
Technically, ASML at ~$1,534 sits below both its 50-day simple moving average ($1,669.83) and its 200-day simple moving average ($1,601.18), even after bouncing about 6% on November 9 from a $1,424.75 close.
High confidenceMarketBeat gives the November 11 averages of $1,669.83 (50-day) and $1,601.18 (200-day). Its November 9 alert shows a 6.2% gain to $1,513.25 from $1,424.75 on above-average volume (about 2.19M shares vs. 1.75M average). Trading below both averages points to a recent downtrend, though the 50-day average is falling toward the 200-day.
ASML closed at $1,495.16 on November 13, 2026, about 25% below its 52-week high of $1,999.96 and up from its 52-week low of $946.11, with a 52-week price change of +44.14%; none of the sources reviewed gave a 6-month return.
High confidenceStockAnalysis lists the Nov 13 close of $1,495.16, the 52-week range of $946.11 to $1,999.96 and a 52-week price change of +44.14% (statistics page updated Nov 15, 2026). The quote and statistics pages reviewed did not show a 6-month return.
The share price ($1,495) is below both the 50-day simple moving average (about $1,660) and the 200-day (about $1,602), while the 50-day is still above the 200-day.
High confidenceStockAnalysis reports a 50-day MA of $1,660.49 and a 200-day MA of $1,602.21. TipRanks shows similar values ($1,689.58 and $1,596.22) and flags both as sell signals with price below them. So the long-term trend structure is intact for now, but the near-term trend has broken down.
The stock fell about 13.6% over 30 days into late October and stayed volatile in November. It fell 6.67% on Nov 5 amid a U.S. chip sell-off, export-control worries and rising bond yields, then rose 6.12% on Nov 9 in a broad AI-stock rally.
Medium confidenceTickeron reports a roughly -13.6% 30-day move (from $1,811.67 to $1,565.90) and about a 5% drop on Oct 30 after Intel and Amazon news. TradingKey attributes the Nov 5 drop to China export-control scrutiny, customer capex caution, higher yields and a sequential dividend cut. StockAnalysis's news feed links the Nov 9 rebound to an AI-stock rally.
ASML declared an interim dividend of €1.88 per share, payable November 4, 2026, for a trailing yield of about 0.53% and reported year-over-year dividend growth of 26.27%; meanwhile the stock is in a weak technical posture, trading at $1,495.16, below its 50-day ($1,660.49) and 200-day ($1,602.21) moving averages with an RSI of 42.19, after a 6.6% one-day drop on October 30.
Medium confidenceThe €1.88 interim dividend is in the primary release, and the yield, dividend growth, moving averages and RSI come from StockAnalysis as of Nov 13. The October 30 drop is reported by Debelegger. Analyst targets conflict across aggregators, for example StockAnalysis's €1,539 average from 44 analysts versus MarketBeat's $1,970 consensus in July, so no single consensus target is cited with high confidence.
In mid-day trading on November 11, 2026, ASML traded at $1,534.42, about 30% below the $2,204.71 average target, which implies roughly 44% upside to consensus.
High confidenceMarketBeat reports the $1,534.42 mid-day price (up 1.8% from a $1,507.85 prior close) next to the $2,204.71 consensus target. The upside figure is calculated: $2,204.71 / $1,534.42 − 1 ≈ 43.7%. Such a wide gap usually means the price has fallen faster than analysts have revised their targets, which matches the pullback described in the technical finding.
Major-bank targets on record are all well above the ~$1,534 price: Bernstein $2,623 (+71%, raised July 6), Wells Fargo $2,500 (+63%, raised from $2,200 on July 16), JPMorgan $2,350 (+53%, cut from $2,400 on October 15), and RBC and Argus at $2,100 each (+37%).
Medium confidenceThe MarketBeat alerts list Wells Fargo's raise to $2,500 (Overweight), JPMorgan's cut from $2,400 to $2,350 (Overweight), RBC's $2,100 Outperform and Argus's $2,100. MarketBeat's July 16 piece records JPMorgan's earlier raise from $2,200 to $2,400 and Bernstein's raise from $1,971 to $2,623 (Outperform). Upside percentages are calculated against $1,534.42. Confidence is medium because the Wells Fargo and Bernstein targets are about four months old and may have changed since.
In the last 90 days (since about August 18, 2026) the documented actions were mostly reiterations and one trim: Cantor Fitzgerald reiterated Overweight (September 14), RBC restated Outperform at $2,100 (October 7), Citigroup reissued Buy (October 15), and JPMorgan cut its target by $50 to $2,350 (October 15). No new Goldman Sachs, Morgan Stanley, BofA or Barclays rating changes were found in this window.
Medium confidenceMarketBeat lists these dated actions; October 15 falls on a Thursday in 2026, which matches the listing. The latest Goldman Sachs action found is an April 15, 2026 Buy reiteration, and Morgan Stanley's latest is a July 7, 2026 Overweight reaffirmation. Barclays (Equal Weight, €650) and Jefferies (Hold, €690) downgrades also turned up, but their euro targets are less than half the current share price, so they appear to be from an earlier cycle and are left out as stale. The only true rating upgrade in the window came from a quant service (Wall Street Zen, Hold to Buy on October 17), not from a bank.
RSI(14) is in neutral territory at about 42 as of mid-November 2026, recovering from oversold readings of about 27 to 29 around November 4–5, 2026.
Medium confidenceStockAnalysis lists an RSI of 42.19 (updated Nov 15). TradingKey reported an RSI of 28.957 on Nov 5 after a 6.67% one-day drop, and Financhill showed an RSI near 27 with the price around $1,356. These are secondary aggregators and their readings vary by date.
Near-term support sits around the early-November low of roughly $1,355, overhead resistance is at the 200-day (about $1,600) and 50-day (about $1,660) averages, and major resistance is the $2,000 area at the 52-week high.
Medium confidenceTickeron names the roughly $2,000 52-week-high zone as major resistance and the early-November low near $1,355 as near-term support. Financhill's roughly $1,356.65 low-RSI reading confirms that trough. The moving-average levels from StockAnalysis act as nearer overhead resistance.
The sell-side remains constructive despite the drawdown. Average 12-month targets range from about $2,138 (StockAnalysis, 41 analysts) to about $2,205 (MarketBeat, 24 analysts), with target lows of $1,415 to $1,450. At $1,495 the stock trades at 38.8x trailing and 23.4x forward earnings.
Medium confidenceStockAnalysis shows a consensus near $2,138 and P/E ratios of 38.77 trailing and 23.44 forward. MarketBeat's Nov 7 alert gives a $2,204.71 consensus, a $1,415 to $2,623 range, and notes JPMorgan cutting its target to $2,350. Targets differ by aggregator.
Q3 2026 net income of about €5.0 billion appears to include non-operating equity-investment gains that cannot be separated from the operating result using the filing: operating income was about €5.2 billion, and a normal tax charge would leave net income well below €5.0 billion, so the jump in basic EPS from €7.59 in Q2 to €12.95 in Q3 probably overstates core earnings growth.
Medium confidenceA secondary analysis says Q3 net income includes equity investment gains that should be kept separate from operating results and puts operating income near €5.2 billion. The primary release does not break out the gain, so its size is inferred, not disclosed.
At the close on November 13, 2026, ASML (NASDAQ) traded at $1,495.16, with a market cap of $564.94 billion, enterprise value of $553.06 billion, trailing P/E of 38.77, forward P/E of 23.44, P/B of 22.47 and EV/EBITDA of 29.99; MarketScreener's Euronext estimates put P/E at 32.1x for 2026E and 23.5x for 2027E.
Medium confidenceStockAnalysis lists these multiples as of the Nov 13 close, the latest data available, not Nov 16. MarketScreener shows a €512 billion market cap and €498 billion EV but marks the page 'inactive instrument', so its figures may be stale. Forward P/E varies widely by estimate year and source.
Against peer Applied Materials (AMAT: $370.50 on Nov 13, 2026, market cap $294.03 billion), ASML trades at a premium on every multiple compared: trailing P/E 38.77 vs 29.36, forward P/E 23.44 vs 19.31, EV/EBITDA 29.99 vs 24.43, and P/B 22.47 vs 11.25, with similar dividend yields (0.53% vs 0.57%).
Medium confidenceBoth companies' statistics pages on the same aggregator show these figures as of the Nov 13, 2026 close, so the comparison uses the same methodology and date.
ASML's balance sheet is net cash: trailing-twelve-month free cash flow was $23.34 billion (operating cash flow $25.06 billion) against total debt of $2.24 billion, and the company held €12,735 million in cash and short-term investments at the end of Q3 2026 while repurchasing about €4.1 billion of shares in the quarter.
Medium confidenceThe cash balance, the €4.1 billion Q3 buyback under the 2026–2028 program, and the dividend come from the primary 6-K. The free cash flow and debt totals come from the aggregator, because the release did not state them.
ASML reported record Q3 2026 net sales of about €11.7 billion, a 57.5% gross margin and net income of about €5 billion, and guided full-year 2026 net sales to €44–45 billion at a gross margin of about 56%.
Medium confidenceSecondary analyses of the October 2026 release report €11.7B in sales, near the high end of guidance, with Installed Base Management at €3.3B (above guidance) lifting the margin. They also report the full-year guidance. One reported Q4 revenue guide of €14.2–15.2B could not be confirmed against ASML's own release. The release reportedly gave no quarterly bookings figure, and customer interest in 2029–2030 orders is not the same as firm bookings. No one-time items were flagged; the margin uplift is attributed to service and upgrade revenue mix, and should be checked against ASML's primary filing.
ASML trades at a trailing P/E of about 37.8 and a market cap of about $591 billion, with the consensus full-year EPS estimate at $46.54.
Medium confidenceMarketBeat lists a P/E of 37.77 and a market cap of $591.40B on November 11, and a current-year EPS estimate of 46.54 on November 9. At $1,534 that is roughly 33x the current-year estimate (calculated). A peer comparison and ASML's own 5-year multiple history were not available within the search budget, so it is not established whether this multiple is high or low by those measures.
The Q3 2026 earnings beat was partly due to a one-time item: net income of about €5.0B included a roughly €500M gain tied to ASML's Mistral AI stake, which should be stripped out when judging underlying operating performance.
Medium confidenceThe earnings call transcript summary says Q3 net income of about €5.0B included a roughly €500M Mistral AI-related gain. Removing it cuts net income by about 10%, so the size of the headline EPS beat overstates the operating beat.
ASML's current trailing P/E of 38.77 and EV/EBITDA of 29.99 sit at the upper end of its FY2022–FY2025 range (P/E 34.3–37.0, EV/EBITDA 27.0–28.8) but below FY2021's peak of 48.8x P/E and 41.0x EV/EBITDA, while its P/B of 22.47 is above FY2023–FY2025 levels (14.4–20.0).
Medium confidenceStockAnalysis's annual ratios table gives fiscal-year-end multiples for FY2021–FY2025 and a current column dated Nov 13, 2026. The data comes from an aggregator, not company filings.
Downside risks named in the coverage include semiconductor export controls and tariffs, the gap between customers' stated long-dated demand and firm orders, and a possible lack of capacity for 2027–28; the upside catalysts named are AI-driven memory and logic investment and High-NA EUV adoption.
Low confidenceSecondary commentary says ASML expects supply to trail 2027–28 demand. Separate Simply Wall St community narratives argue the bear case (export controls and tariffs) and the bull case (High-NA EUV and AI). Confidence is low because these are opinion pieces, not primary disclosures.
Sources (32)
- https://www.sec.gov/Archives/edgar/data/0000937966/000162828026065813/pressreleasefinancialresul.htmfundamentalsPrimary
- https://seekingalpha.com/pr/20684919fundamentalsPrimary
- https://vestedfinance.com/blog/us-stocks/asml-q3-earnings-2026/fundamentalsSecondary
- https://letsdatascience.com/news/asml-reports-record-q3-sales-and-raises-outlook-c553b961fundamentalsSecondary
- https://stockanalysis.com/stocks/asml/statistics/fundamentalsSecondary
- https://stockanalysis.com/stocks/asml/financials/ratios/fundamentalsSecondary
- https://stockanalysis.com/stocks/amat/statistics/fundamentalsSecondary
- https://ca.marketscreener.com/quote/stock/ASML-HOLDING-6268/valuation/fundamentalsSecondary
- https://www.debelegger.nl/en/stock/ASML.USfundamentalsSecondary
- https://stockanalysis.com/quote/ams/ASML/forecast/fundamentalsSecondary
- https://www.marketbeat.com/instant-alerts/price-asml-nasdaq-asml-stock-jumps-18-whats-next-2026-11-11/analyst_targetsSecondary
- https://www.marketbeat.com/instant-alerts/price-asml-nasdaq-asml-stock-price-up-62-time-to-buy-2026-11-09/analyst_targetsSecondary
- https://www.marketbeat.com/instant-alerts/asml-nasdaqasml-stock-price-expected-to-rise-jpmorgan-chase-co-analyst-says-2026-07-16/analyst_targetsSecondary
- https://www.marketbeat.com/instant-alerts/asml-nasdaqasml-earns-buy-rating-from-the-goldman-sachs-group-2026-04-15/analyst_targetsSecondary
- https://uk.investing.com/equities/asml-holdings-consensus-estimatesanalyst_targetsSecondary
- https://www.alphaspread.com/security/xmun/asme/analyst-estimatesanalyst_targetsSecondary
- https://www.tipranks.com/news/the-fly/asml-downgraded-to-equal-weight-from-overweight-at-barclays-theflyanalyst_targetsSecondary
- https://www.tipranks.com/news/the-fly/asml-downgraded-to-hold-from-buy-at-jefferies-theflyanalyst_targetsSecondary
- https://beancount.io/blog/2026/10/20/asml-fy2026-q3-earnings-analysisanalyst_targetsSecondary
- https://braindetox.kr/en/posts/asml_orders_ai_investment_slowdown_2026.htmlanalyst_targetsUnreliable
- https://simplywall.st/community/narratives/nl/semiconductors/ams-asml/asml-holding-shares/0aa3el2n-export-controls-and-tariffs-will-disrupt-semiconductor-supply-chainsanalyst_targetsUnreliable
- https://simplywall.st/narratives/high-na-technology-and-ai-markets-ignite-exciting-growth-opportunitiesanalyst_targetsUnreliable
- https://investor.asml.com/static-files/44d4bee1-b2f9-41b7-b3f8-1bf28f993fe6technicalsPrimary
- https://stockanalysis.com/stocks/asml/technicalsSecondary
- https://www.tipranks.com/stocks/asml/technical-analysistechnicalsSecondary
- https://financhill.com/stock-price-chart/asml-technical-analysistechnicalsSecondary
- https://www.investing.com/news/transcripts/earnings-call-transcript-asml-tops-q3-2026-estimates-but-shares-fall-93CH-4948118technicalsSecondary
- https://www.marketbeat.com/instant-alerts/consensus-asml-holding-nv-nasdaq-asml-stock-has-consensus-target-price-of-220471-2026-11-07/technicalsSecondary
- https://tickeron.com/ticker/ASML/technicalsSecondary
- https://tickeron.com/blogs/asml-holding-asml-weighing-the-path-to-the-2-140-analyst-target-32184/technicalsSecondary
- https://www.tradingkey.com/news/market-movers/262282914-market-movers-asml-20261105technicalsUnreliable
- https://www.tradingkey.com/news/market-movers/262296656-market-movers-asml-20261109technicalsUnreliable
Caveats
Time sensitivity: prices and multiples come from the November 13, 2026 close [5][16] or from November 9–11 intraday snapshots [4][9], not from November 16. Figures differ by date and source, for example market cap of $564.94B [16] vs $591.40B [20] and trailing P/E of 38.77 [16] vs 37.77 [20]. Consensus targets are not consistent across aggregators. MarketBeat shows $2,204.71 from 24 ratings [3]. StockAnalysis is cited at about $2,138 from 41 analysts in one finding [14] but at €1,539 from 44 analysts in another [8]. Investing.com shows about $2,137 and AlphaSpread €2,127.38 for the Euro listing [3]. No median target was found [3]. Some bank targets are about four months old (Bernstein, Wells Fargo) [10]. The Barclays and Jefferies euro targets were left out as stale [11]. The Mistral AI gain (about €500M) comes from a transcript summary and the operating-income estimate from a secondary analysis. The primary filing does not break out the gain, so the normalized earnings figure is approximate [15][21]. One source cites a 'sequential dividend cut' [7] while another reports 26.27% year-over-year dividend growth [8]. Interim dividends can differ in timing from final dividends, so this was not reconciled. Free cash flow, debt, multiples, moving averages, RSI and historical ratios come from secondary aggregators, not company filings [6][12][18][22]. Technical readings vary by provider and date [6][12]. Risk and catalyst themes rest on low-confidence opinion pieces [23]. Not covered: quarterly net bookings (not disclosed) [2], 6-month return [5], customer or regional revenue mix, a detailed segment breakdown of EUV versus DUV, the size of China exposure, and a full peer set beyond Applied Materials. This report presents evidence only and is not a buy, sell or hold recommendation.
This report is for informational purposes only and is not investment advice. No buy / sell / hold recommendation is made or implied.
More research reports
Recent reports from the same pipeline. See all examples